Home
>
National Drug Code (NDC)
>
Myozyme
Myozyme - 58468-0150-1 - (ALGLUCOSIDASE ALFA)
Drug Information of Myozyme
| Product NDC: | 58468-0150 |
| Proprietary Name: | Myozyme |
| Non Proprietary Name: | ALGLUCOSIDASE ALFA |
| Active Ingredient(s): | 5 mg/mL & nbsp; ALGLUCOSIDASE ALFA |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Myozyme
| Product NDC: | 58468-0150 |
| Labeler Name: | Genzyme Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA125141 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20100619 |
Package Information of Myozyme
| Package NDC: | 58468-0150-1 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (58468-0150-1) > 10.5 mL in 1 VIAL, SINGLE-USE |
NDC Information of Myozyme
| NDC Code | 58468-0150-1 |
| Proprietary Name | Myozyme |
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (58468-0150-1) > 10.5 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 58468-0150 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ALGLUCOSIDASE ALFA |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20100619 |
| Marketing Category Name | BLA |
| Labeler Name | Genzyme Corporation |
| Substance Name | ALGLUCOSIDASE ALFA |
| Strength Number | 5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | alpha-Glucosidases [Chemical/Ingredient],Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] |
